Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Anesthesia
Published in: Journal of Anesthesia 3/2021

01-06-2021 | Transesophageal Echocardiography | Special Feature: Special Article

Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic

Authors: Naoyuki Hirata, Michiaki Yamakage

Published in: Journal of Anesthesia | Issue 3/2021

Login to get access

Abstract

The coronavirus disease (COVID-19) pandemic has brought critical challenges to anesthesiologists and perioperative practice. Whereas anesthesiologists may be primarily concerned with airway and respiratory management, the COVID-19 data accumulated to date indicate that primary and/or secondary cardiovascular complications are common. Previous studies have demonstrated that the mortality rate is significantly higher in patients with cardiovascular disease (CVD) than in patients without CVD. Dysregulation of immune function in patients with CVD may be involved in the prognosis of COVID-19 patients. Anesthesia and surgical procedures can modulate the immune system, and some patients undergoing surgery, particularly those undergoing cardiovascular procedures, have CVD. In perioperative management for patients with suspected or diagnosed COVID-19 and those who have recovered from COVID-19, it is important for anesthesiologists to be concerned not only with airway and respiratory management, but also with cardiovascular complications and perioperative circulatory management to control the progression of the disease in patients with COVID-19.
Literature
1.
Yamakage M. Anesthesia in times of COVID-19. J Anesth. 2020;25:1–5.
2.
Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin–angiotensin–aldosterone system blocker and the risk of COVID-19. N Engl J Med. 2020;382:2431–40.CrossRef
3.
4.
5.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhan J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1601–9.
6.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xia Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.CrossRef
7.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020.
8.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–81.CrossRef
9.
10.
11.
Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Investig. 2009;39:618–25.CrossRef
12.
13.
Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, Avidan A, Beeri R, Weissman C, Jaffe AS, Sprung CL. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J. 2012;33:895–903.CrossRef
14.
Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007;35:1599–608.CrossRef
15.
Kawaguchi R, Hirata N, Yokinaga Y, Hayashi S, Inoue S, Watanabe N, Yamakage M. Nitrite administration improves sepsis-induced myocardial and mitochondrial dysfunction by modulating stress signal responses. J Anesth. 2017;31:885–94.CrossRef
16.
17.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characteristics and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–74.CrossRef
18.
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–90.CrossRef
19.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jian RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.CrossRef
20.
Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu W, Peng C, Zhang YJ, Luo CM, Tan B, Wang N, Zhu Y, Crameri G, Zhang SY, Wang LF, Daszak D, Shi ZL. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503:535–8.CrossRef
21.
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus induced lung injury. Nat Med. 2005;11:875–9.CrossRef
22.
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Nigoghossian CD, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352–71.CrossRef
23.
Roshanov PS, Rochwerg B, Patel A, Salehian O, Duceppe E, Belley-Côté EP, Guyatt GH, Sessler DI, Manach YL, Borges FK, Tandon V, Worster A, Thompson A, Koshy M, Devereaux B, Spencer FA, Sanders RD, Sloan EN, Morley EE, Paul J, Raymer KE, Punthakee Z, Devereaux PJ. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort. Anesthesiology. 2017;126:16–27.CrossRef
24.
Jor O, Maca J, Koutna J, Gemrotova M, Vymazal T, Litschmannova M, Sevcik P, Reimer P, Mikulova V, Trlicova M, Cerny V. Hypotension after induction of general anesthesia: occurrence, risk factors, and therapy. A prospective multicenter observational study. J Anesth. 2018;32:673–80.CrossRef
25.
Ida M, Naito Y, Matsunari Y, Tanaka Y, Inoue S, Kawaguchi M. Prevalence and associated factors of preoperative functional disability in elective surgical patients over 55 years old: a prospective cohort study. J Anesth. 2018;32:381–6.CrossRef
26.
Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605–10.CrossRef
27.
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531–8.CrossRef
28.
Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020;14:125–8.CrossRef
29.
Singh MV, Chapleau MW, Harwani SC, Abboud FM. The Immune system and hypertension. Immunol Res. 2014;59:243–53.CrossRef
30.
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Investig. 2017;127:1–4.CrossRef
31.
Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15:104–16.CrossRef
32.
Libby P, Ridker PM, Hansson GK. Leducq transatlantic network on atherothrombosis inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129–38.CrossRef
33.
Liu WM, van der Zeijst BA, Boog CJ, Soethout EC. Aging and impaired immunity to influenza viruses: implications for vaccine development. Hum Vaccin. 2011;7(Suppl):94–8.CrossRef
34.
Rossint J, Zarbock A. Anesthesia-induced immune modulation. Curr Opin Anaesthesiol. 2019;32:799–805.CrossRef
35.
Boavista BHL, Leme SP, Ferreira CF, Rieken MRP. Immunomodulatory effects of anesthetic agents in perioperative medicine. Minerva Anesthesiol. 2020;86:181–95.
36.
Ng KT, Van Paassen J, Langan C, Sarode DP, Arbous MS, Alston RP, Dekkers OM. The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg. 2020;57:620–7.CrossRef
37.
Warren OJ, Smith AJ, Alexiou C, Rogers PLB, Jawad N, Vincent C, Darzi AW, Athanasiou T. The inflammatory response to cardiopulmonary bypass: part 1-mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23:223–31.CrossRef
38.
39.
He H, Zhao S, Han L, Wang Q, Xia H, Huang X, Yao S, Huang J, Chen X. Anesthetic management of patients undergoing aortic dissection repair with suspected severe acute respiratory syndrome COVID-19 infection. J Cardiothorac Vasc Anesth. 2020;34:1402–5.CrossRef
40.
41.
He Y, Wei J, Bian J, Buo K, Lu J, Mei W, Ma J, Xia Z, Xu M, Yan F, Yu C, Wang E, Wang W, Zeng N, Wang S, Xu J, Huang Y, Huang J. Chinese Society of Anesthesiology experts consensus on anesthetic management of cardiac surgical patients with suspected or confirmed coronavirus disease 2019. J Cardiothorc Vasc Anesth. 2020;34:1397–401.CrossRef
42.
Zhao S, Ling K, Yan H, Zhong L, Peng X, Yao S, Huang J, Chen X. Anesthetic management of patients with COVID-19 infections during emergency procedures. J Cardiothorac Vasc Anesth. 2020;34:1125–31.CrossRef
43.
Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, Kurz A. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126:47–65.CrossRef
44.
Kirkpatrick JN, Mitchell C, Taub C, Kort S, Hung J, Swaminathan M. ASE statement on protection of patients and echocardiography society providers during the 2019 novel coronavirus outbreak: endorsed by the American College of Cardiology. J Am Coll Cardiol. 2020;75:3078–84.CrossRef
45.
Markin NW, Cawcutt KA, Sayyed SH, Rupp ME, Lisco SJ. Transesophageal echocardiography probe sheath to decrease provider and environment contamination. Anesthesiology. 2020;133:475–7.CrossRef
Metadata
Title
Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic
Authors
Naoyuki Hirata
Michiaki Yamakage
Publication date
01-06-2021
Publisher
Springer Singapore
Published in
Journal of Anesthesia / Issue 3/2021
Print ISSN: 0913-8668
Electronic ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-020-02852-1

Other articles of this Issue 3/2021

Journal of Anesthesia 3/2021 Go to the issue

Letter to the Editor

Reply to a Letter to the Editor

Special Feature: Special Article

Air contamination with SARS-CoV-2 in the operating room

Original Article

Clinical profiles and outcome of patients with COVID-19 in a specialized hospital in Japan

Letter to the Editor

The uterine contraction evaluation is tricky in the in vivo

Special Feature: Special Article

Anesthesiologist behavior and anesthesia machine use in the operating room during the COVID-19 pandemic: awareness and changes to cope with the risk of infection transmission

Editorial

Anesthesia in the times of COVID-19